Emma Pailler

1.1k total citations
18 papers, 723 citations indexed

About

Emma Pailler is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Emma Pailler has authored 18 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cancer Research, 16 papers in Pulmonary and Respiratory Medicine and 13 papers in Oncology. Recurrent topics in Emma Pailler's work include Cancer Genomics and Diagnostics (16 papers), Lung Cancer Treatments and Mutations (13 papers) and Cancer Cells and Metastasis (9 papers). Emma Pailler is often cited by papers focused on Cancer Genomics and Diagnostics (16 papers), Lung Cancer Treatments and Mutations (13 papers) and Cancer Cells and Metastasis (9 papers). Emma Pailler collaborates with scholars based in France, Netherlands and United States. Emma Pailler's co-authors include Françoise Farace, Marianne Oulhen, David Planchard, Benjamin Besse, Nathalie Auger, Philippe Vielh, Isabelle Borget, Jean‐Charles Soria, Vincent Faugeroux and Mélissa Taylor and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Emma Pailler

15 papers receiving 714 citations

Peers

Countries citing papers authored by Emma Pailler

Since Specialization

Citations

This map shows the geographic impact of Emma Pailler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Pailler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Pailler more than expected).

Fields of papers citing papers by Emma Pailler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Pailler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Pailler. The network helps show where Emma Pailler may publish in the future.

Co-authorship network of co-authors of Emma Pailler

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Pailler. A scholar is included among the top collaborators of Emma Pailler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Pailler. Emma Pailler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in ALK -Rearranged Non–Small-Cell Lung Cancer 2019 ·Clinical Cancer Research ·Emma Pailler, Vincent Faugeroux, Marianne Oulhen, Laura Mezquita, Mélanie Laporte, Aurélie Honoré, Yann Lécluse, (unknown), Maud Ngo‐Camus, Claudio Nicotra, Jordi Remón, Ludovic Lacroix, David Planchard, Luc Friboulet, Benjamin Besse, Françoise Farace	92
2	Circulating tumor cells (CTCs) for the noninvasive monitoring and personalization of non-small cell lung cancer (NSCLC) therapies 2019 ·Journal of Thoracic Disease ·Patrycja Pawlikowska, Vincent Faugeroux, Marianne Oulhen, (unknown), (unknown), Emma Pailler, Françoise Farace	23
3	Abstract 5600: Establishment and characterization of a unique circulating tumor cells-derived xenograft (CDX) in prostate cancer 2018 ·Cancer Research ·Vincent Faugeroux, Emma Pailler, Olivier Déas, Virginie Marty, (unknown), Kiki Andree, Jean‐Yves Scoazec, Nikolas H. Stoecklein, Nicolò Manaresi, Dominique Tramalloni, Maud Ngo‐Camus, Claudio Nicotra, Leon W.M.M. Terstappen, Valérie Lapierre, Karim Fizazi, Yohann Loriot, Jean‐Gabriel Judde, Françoise Farace	0
4	An amplicon-based liquid biopsy for detecting ALK and ROS1 fusions and resistance mutations in advanced non-small cell lung cancer (NSCLC) patients. 2018 ·Journal of Clinical Oncology ·Laura Mezquita, Cécile Jovelet, Ludovic Lacroix, David Planchard, Gonzalo Recondo, Emma Pailler, Édouard Auclin, Vincent Plagnol, Karen Howarth, Clive Morris, Emma Green, Étienne Rouleau, Claudio Nicotra, Caroline Caramella, Julien Adam, Nathalie Auger, Françoise Farace, Luc Friboulet, Benjamin Besse	0
5	Analysis of single circulating tumor cells (CTCs) to identify resistance mutations to ALK-inhibitors in both ALK-gene and bypass oncogenic pathways. 2018 ·Journal of Clinical Oncology ·Emma Pailler, Laura Mezquita, Vincent Faugeroux, Marianne Oulhen, (unknown), Jordi Remón, Aurélie Honoré, Mélanie Laporte, Claudio Forcato, Yann Lécluse, Ludovic Lacroix, Virginie Marty, Maud Ngo‐Camus, Claudio Nicotra, David Planchard, Jean‐Charles Soria, Nicolò Manaresi, Françoise Farace, Benjamin Besse	3
6	Circulating Tumor Cells with Aberrant ALK Copy Number Predict Progression-Free Survival during Crizotinib Treatment in ALK -Rearranged Non–Small Cell Lung Cancer Patients 2017 ·Cancer Research ·Emma Pailler, Marianne Oulhen, Isabelle Borget, Jordi Remón, (unknown), Nathalie Auger, Fanny Billiot, Maud Ngo Camus, Frédéric Commo, Colin R. Lindsay, David Planchard, Jean‐Charles Soria, Benjamin Besse, Françoise Farace	59
7	A prospective examination of circulating tumor cell profiles in non-small-cell lung cancer molecular subgroups 2017 ·Annals of Oncology ·Colin R. Lindsay, Vincent Faugeroux, Stefan Michiels, Emma Pailler, Fabio Facchinetti, Dan Ou, M.V. Bluthgen, (unknown), Maud Ngo‐Camus, (unknown), Caroline Caramella, Fanny Billiot, Jordi Remón, David Planchard, Jean‐Charles Soria, Benjamin Besse, Françoise Farace	73
8	Detection of Gene Rearrangements in Circulating Tumor Cells: Examples of ALK-, ROS1-, RET-Rearrangements in Non-Small-Cell Lung Cancer and ERG-Rearrangements in Prostate Cancer 2017 ·Advances in experimental medicine and biology ·Cyril Catelain, Emma Pailler, Marianne Oulhen, Vincent Faugeroux, (unknown), Françoise Farace	12
9	Routine clinical use of circulating tumor cells for diagnosis of mutations and chromosomal rearrangements in non-small cell lung cancer—ready for prime-time? 2017 ·Translational Lung Cancer Research ·Emma Pailler, Vincent Faugeroux, Marianne Oulhen, Cyril Catelain, Françoise Farace	12
10	Filter-Adapted Fluorescent In Situ Hybridization (FA-FISH) for Filtration-Enriched Circulating Tumor Cells 2017 ·Methods in molecular biology ·Marianne Oulhen, Emma Pailler, Vincent Faugeroux, Françoise Farace	0
11	Whole-exome sequencing of single circulating tumor cells is a useful tool for studying the intrapatient genetic heterogeneity in metastatic prostate cancer. 2017 ·Journal of Clinical Oncology ·Vincent Faugeroux, Céline Lefèbvre, Emma Pailler, (unknown), Fanny Billiot, Charles Marcaillou, (unknown), Philippe Vielh, Semih Doğan, Philippe Rameau, Maud Ngo‐Camus, Christophe Massard, Jean‐Charles Soria, Karim Fizazi, Arjan G.J. Tibbe, Sylvia Julien, Yohann Loriot, Françoise Farace	3
12	Method for semi-automated microscopy of filtration-enriched circulating tumor cells 2016 ·BMC Cancer ·Emma Pailler, Marianne Oulhen, Fanny Billiot, (unknown), Nathalie Auger, Vincent Faugeroux, Corinne Laplace‐Builhé, Benjamin Besse, Yohann Loriot, Maud Ngo‐Camus, (unknown), Colin R. Lindsay, Jean‐Charles Soria, Philippe Vielh, Françoise Farace	29
13	The potential diagnostic power of circulating tumor cell analysis for non-small-cell lung cancer 2015 ·Expert Review of Molecular Diagnostics ·(unknown), Emma Pailler, Vincent Faugeroux, Mélissa Taylor, Marianne Oulhen, Nathalie Auger, David Planchard, Jean‐Charles Soria, Colin R. Lindsay, Benjamin Besse, Philippe Vielh, Françoise Farace	21
14	High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer 2015 ·Annals of Oncology ·Emma Pailler, Nathalie Auger, Colin R. Lindsay, Philippe Vielh, (unknown), Isabelle Borget, Maud Ngo‐Camus, David Planchard, Jean‐Charles Soria, (unknown), F Farace	96
15	Clinical Utility of Circulating Tumor Cells in ALK-Positive Non-Small-Cell Lung Cancer 2014 ·Frontiers in Oncology ·Vincent Faugeroux, Emma Pailler, Nathalie Auger, Mélissa Taylor, (unknown)	23
16	Detection of Circulating Tumor Cells Harboring a Unique ALK Rearrangement in ALK-Positive Non–Small-Cell Lung Cancer 2013 ·Journal of Clinical Oncology ·Emma Pailler, Julien Adam, Amélie Barthelemy, Marianne Oulhen, Nathalie Auger, Alexander Valent, Isabelle Borget, David Planchard, Mélissa Taylor, Fabrice André, Jean Charles Soria, Philippe Vielh, Benjamin Besse, Françoise Farace	221
17	Abstract 1470: Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small cell lung cancer. 2013 ·Cancer Research ·Emma Pailler, Julien Adam, Amélie Barthelemy, Marianne Oulhen, Nathalie Auger, Alexander Valent, David Planchard, Mélissa Taylor, Isabelle Borget, Fabrice André, Jean‐Charles Soria, Philippe Vielh, Benjamin Besse, Françoise Farace	1
18	Circulating Tumor Cells in Lung Cancer 2012 ·Acta Cytologica ·(unknown), Emma Pailler, Fanny Billiot, Françoise Drusch, Amélie Barthelemy, Marianne Oulhen, Benjamin Besse, Jean‐Charles Soria, Françoise Farace, Philippe Vielh	55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact